Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
31.06
-1.08 (-3.35%)
At close: Jul 20, 2026, 4:00 PM EDT
31.05
0.00 (-0.02%)
Pre-market: Jul 21, 2026, 4:11 AM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.85 billion as of July 21, 2026. Its market cap has increased by 234.26% in one year.
Market Cap
1.85B
Enterprise Value
1.47B
1-Year Change
234.26%
Ranking
Category
Stock Price
$31.06
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.85B, an increase of 182.12%. That is a compound annual growth rate of 23.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.85B | 31.62% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 1.97B |
| Ocular Therapeutix | 1.96B |
| Lakefront Biotherapeutics NV | 1.96B |
| UroGen Pharma | 1.96B |
| Harmony Biosciences Holdings | 1.96B |
| Damora Therapeutics | 1.94B |
| Nanobiotix | 1.91B |
| Taysha Gene Therapies | 1.91B |